StockIQStockIQ.tech

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis

--

Free AI-powered analysis and research for Rhythm Pharmaceuticals, Inc. stock

Sector: Healthcare

Full RYTM report

Rhythm Pharmaceuticals, Inc. (RYTM) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.

Analyze RYTM Now β†’

πŸ“° Latest Update

Rhythm Pharmaceuticals stock surges 28% on AstraZeneca bid report

Rhythm Pharmaceuticals (NASDAQ) shares jumped 28% after The Wall Street Journal reported that AstraZeneca (NASDAQ) made a $10 billion acquisition offer for the company, proposing $124 per share. Following the news, Rhythm's stock closed at $110.68, raising its market capitalization to approximately $7.7 billion. The acquisition would enhance AstraZeneca's portfolio in rare disease treatments, as Rhythm focuses on therapies for rare metabolic disorders.

Read full article β†’

History

People also watch

AMGN
Amgen Inc.
--
JNJ
Johnson & Johnson
--
GILD
Gilead Sciences Inc.
--
SANA
Sana Biotechnology, Inc.
--
UTHR
United Therapeutics Corporation
--